LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 199

Search options

  1. Article: Diagnostic Tools for Sarcopenia: Can We Get Less Expensive and Accurate Methods?

    Setiati, Siti

    Acta medica Indonesiana

    2019  Volume 51, Issue 2, Page(s) 93–94

    Abstract: Sarcopenia, as defined by the European Working Group on Sarcopenia (EWGSOP) in Older People is "a progressive and generalized skeletal muscle disorder that is associated with increased likelihood of adverse outcomes including falls, fractures, physical ... ...

    Abstract Sarcopenia, as defined by the European Working Group on Sarcopenia (EWGSOP) in Older People is "a progressive and generalized skeletal muscle disorder that is associated with increased likelihood of adverse outcomes including falls, fractures, physical disability, and mortality". The first EWGSOP and Asian Working Group for Sarcopenia used muscle mass to define sarcopenia, which is diagnosed by using Dual-energy X-Ray absorptiometry (DXA). However, the cut-off from several countries in Asian showed different cut-off value for different age groups and BMI. In addition, not all hospitals and countries can afford DXA to be used as daily diagnostic routine for sarcopenia.In 2018, EWGSOP made a revision regarding sarcopenia, as well as the diagnostic test and cut-off value (EWGSOP2). EWGSOP2 recommends using self-questionnaire, known as SARC-F as sarcopenia screening, especially in community-dwelling elderly. SARC-F consisted of 5 questions regarding patient's perception of his or her limitations in strength, walking ability, rising from a chair, stair climbing and experiences with falls. This is more feasible to be done in countries without advanced muscle mass measurement tools. Several parameters in sarcopenia are muscle strength, muscle quantity, and physical performance. In muscle strength, measuring grip strength can be done as predictor for patients' outcomes, such as hospitalization and quality of life. For muscle quantity, the gold standards are Magnetic resonance imaging (MRI) and computed tomography (CT). However, since both are expensive, and the cut-off points have not been defined yet, DXA and Bioelectrical impedance analysis (BIA) can be a substitute. Current evidence showed that DXA still does not give consistent results and not yet portable for the use in the community. On the other hand, BIA measure muscle mass using the whole-body electrical conductivity and less expensive than the other tools, thus can be used in the community setting. However, there is no specific cut-off for BIA especially in elderly. For physical performance, several tests can be done, such as gait speed and Timed-Up and Go test (TUG).
    MeSH term(s) Absorptiometry, Photon/economics ; Aged ; Electric Impedance ; Geriatric Assessment ; Hand Strength ; Humans ; Muscle, Skeletal/pathology ; Reference Values ; Sarcopenia/diagnosis ; Sarcopenia/diagnostic imaging ; Surveys and Questionnaires
    Language English
    Publishing date 2019-08-02
    Publishing country Indonesia
    Document type Editorial
    ZDB-ID 2474707-5
    ISSN 2338-2732 ; 0125-9326
    ISSN (online) 2338-2732
    ISSN 0125-9326
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Retraction: Denosumab's Therapeutic Effect for Future Osteosarcopenia Therapy: A Systematic Review and Meta-Analysis.

    Aryana, I Gusti Putu Suka / Rini, Sandra Surya / Setiati, Siti

    Annals of geriatric medicine and research

    2023  Volume 27, Issue 4, Page(s) 361

    Language English
    Publishing date 2023-12-29
    Publishing country Korea (South)
    Document type Retraction of Publication
    ZDB-ID 3035056-6
    ISSN 2508-4909 ; 2508-4798
    ISSN (online) 2508-4909
    ISSN 2508-4798
    DOI 10.4235/agmr.22.0139.r1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Diagnostic Tools for Sarcopenia

    Siti Setiati

    Acta Medica Indonesiana, Vol 51, Iss

    Can We Get Less Expensive and Accurate Methods?

    2019  Volume 2

    Abstract: Sarcopenia, as defined by the European Working Group on Sarcopenia (EWGSOP) in Older People is “a progressive and generalized skeletal muscle disorder that is associated with increased likelihood of adverse outcomes including falls, fractures, physical ... ...

    Abstract Sarcopenia, as defined by the European Working Group on Sarcopenia (EWGSOP) in Older People is “a progressive and generalized skeletal muscle disorder that is associated with increased likelihood of adverse outcomes including falls, fractures, physical disability, and mortality”. The first EWGSOP and Asian Working Group for Sarcopenia used muscle mass to define sarcopenia, which is diagnosed by using Dual-energy X-Ray absorptiometry (DXA). However, the cut-off from several countries in Asian showed different cut-off value for different age groups and BMI. In addition, not all hospitals and countries can afford DXA to be used as daily diagnostic routine for sarcopenia. In 2018, EWGSOP made a revision regarding sarcopenia, as well as the diagnostic test and cut-off value (EWGSOP2). EWGSOP2 recommends using self-questionnaire, known as SARC-F as sarcopenia screening, especially in community-dwelling elderly. SARC-F consisted of 5 questions regarding patient’s perception of his or her limitations in strength, walking ability, rising from a chair, stair climbing and experiences with falls. This is more feasible to be done in countries without advanced muscle mass measurement tools. Several parameters in sarcopenia are muscle strength, muscle quantity, and physical performance. In muscle strength, measuring grip strength can be done as predictor for patients’ outcomes, such as hospitalization and quality of life. For muscle quantity, the gold standards are Magnetic resonance imaging (MRI) and computed tomography (CT). However, since both are expensive, and the cut-off points have not been defined yet, DXA and Bioelectrical impedance analysis (BIA) can be a substitute. Current evidence showed that DXA still does not give consistent results and not yet portable for the use in the community. On the other hand, BIA measure muscle mass using the whole-body electrical conductivity and less expensive than the other tools, thus can be used in the community setting. However, there is no specific cut-off for BIA especially in ...
    Keywords sarcopenia ; the European Working Group on Sarcopenia (EWGSOP) ; SARC-F ; Internal medicine ; RC31-1245
    Subject code 796
    Language English
    Publishing date 2019-08-01T00:00:00Z
    Publisher Interna Publishing
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Improvement of scoring system used before discharge to predict 30-day all-cause unplanned readmission in geriatric population: a prospective cohort study.

    Setiati, Siti / Ardian, Laurentius Johan / Fitriana, Ika / Azwar, Muhammad Khifzhon

    BMC geriatrics

    2024  Volume 24, Issue 1, Page(s) 281

    Abstract: Background: Data taken from tertiary referral hospitals in Indonesia suggested readmission rate in older population ranging between 18.1 and 36.3%. Thus, it is crucial to identify high risk patients who were readmitted. Our previous study found several ... ...

    Abstract Background: Data taken from tertiary referral hospitals in Indonesia suggested readmission rate in older population ranging between 18.1 and 36.3%. Thus, it is crucial to identify high risk patients who were readmitted. Our previous study found several important predictors, despite unsatisfactory discrimination value.
    Methods: We aimed to investigate whether comprehensive geriatric assessment (CGA) -based modification to the published seven-point scoring system may increase the discrimination value. We conducted a prospective cohort study in July-September 2022 and recruited patients aged 60 years and older admitted to the non-surgical ward and intensive coronary care unit. The ROC curve was made based on the four variables included in the prior study. We conducted bivariate and multivariate analyses, and derived a new scoring system with its discrimination value.
    Results: Of 235 subjects, the incidence of readmission was 32.3% (95% CI 26-38%). We established a new scoring system consisting of 4 components. The scoring system had maximum score of 21 and incorporated malignancy (6 points), delirium (4 points), length of stay ≥ 10 days (4 points), and being at risk of malnutrition or malnourished (7 points), with a good calibration test. The C-statistic value was 0.835 (95% CI 0.781-0.880). The optimal cut-off point was ≥ 8 with a sensitivity of 90.8% and a specificity of 54.7%.
    Conclusions: Malignancy, delirium, length of stay ≥ 10 days, and being at risk of malnutrition or malnourished are predictors for 30-day all-cause unplanned readmission. The sensitive scoring system is a strong model to identify whether an individual is at higher risk for readmission. The new CGA-based scoring system had higher discrimination value than that of the previous seven-point scoring system.
    MeSH term(s) Humans ; Aged ; Middle Aged ; Patient Readmission ; Patient Discharge ; Prospective Studies ; Delirium ; Malnutrition ; Neoplasms ; Risk Factors ; Retrospective Studies
    Language English
    Publishing date 2024-03-25
    Publishing country England
    Document type Journal Article
    ZDB-ID 2059865-8
    ISSN 1471-2318 ; 1471-2318
    ISSN (online) 1471-2318
    ISSN 1471-2318
    DOI 10.1186/s12877-024-04875-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Translation and Adaptation of Foreign Questionnaire: The First Step Should be Done Before Used.

    Setiati, Siti

    Acta medica Indonesiana

    2017  Volume 49, Issue 1, Page(s) 1–2

    MeSH term(s) Humans ; Indonesia ; Pacemaker, Artificial ; Quality of Life ; Reproducibility of Results ; Surveys and Questionnaires
    Language English
    Publishing date 2017-04-24
    Publishing country Indonesia
    Document type Editorial ; Comment
    ZDB-ID 2474707-5
    ISSN 2338-2732 ; 0125-9326
    ISSN (online) 2338-2732
    ISSN 0125-9326
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Denosumab's Therapeutic Effect for Future Osteosarcopenia Therapy : A Systematic Review and Meta-Analysis.

    Aryana, I Gusti Putu Suka / Rini, Sandra Surya / Setiati, Siti

    publication RETRACTED

    Annals of geriatric medicine and research

    2023  Volume 27, Issue 1, Page(s) 32–41

    Abstract: Background: Osteosarcopenia, a combination of osteopenia/osteoporosis and sarcopenia, is a common condition among older adults. While numerous studies and meta-analyses have been conducted on the treatment of osteoporosis, the pharmacological treatment ... ...

    Abstract Background: Osteosarcopenia, a combination of osteopenia/osteoporosis and sarcopenia, is a common condition among older adults. While numerous studies and meta-analyses have been conducted on the treatment of osteoporosis, the pharmacological treatment of osteosarcopenia still lacks evidence. Denosumab, a human monoclonal antibody, has shown encouraging results for the treatment of osteosarcopenia. Our systematic review and meta-analysis aimed to investigate the potential dual role of denosumab as an anti-resorptive agent and for other beneficial muscle-related effects in patients with osteosarcopenia, and to evaluate whether denosumab can be a treatment of choice compared to bisphosphonate.
    Methods: Relevant literature was collated from the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, and Google Scholar databases. The primary outcome was denosumab's effect on lumbar spine bone mineral density (LS BMD), handgrip strength, and gait speed change. The secondary outcome was the effect of denosumab on appendicular lean mass (ALM). The outcomes were presented as mean difference (MD). A random effects model was used in the analysis to represent the population. The risk of bias was assessed using funnel plots.
    Results: Out of the 3,074 studies found, four full-text studies met the inclusion criteria, including 264 and 244 participants in the intervention and control groups, respectively. Regarding a primary outcome, our meta-analysis showed that denosumab showed no significant differences in LS BMD and gait speed changes compared to other agents-MD=0.37, 95% confidence interval (CI), -0.35 to 0.79; p=0.09 and MD=0.11; 95% CI, -0.18 to 0.40; p=0.46, respectively. Denosumab had a significant effect on handgrip strength change compared to standard agents-MD=5.16; 95% CI, 1.38 to 18.94; p=0.007, based on the random effects model.
    Conclusions: Denosumab was better than bisphosphonate and placebo in improving muscle strength (handgrip strength). Therefore, denosumab may be favored in individuals with osteosarcopenia to improve muscular performance and reduce fall risk.
    Language English
    Publishing date 2023-01-11
    Publishing country Korea (South)
    Document type Journal Article ; Retracted Publication
    ZDB-ID 3035056-6
    ISSN 2508-4909 ; 2508-4798
    ISSN (online) 2508-4909
    ISSN 2508-4798
    DOI 10.4235/agmr.22.0139
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Translation and Adaptation of Foreign Questionnaire

    Siti Setiati

    Acta Medica Indonesiana, Vol 49, Iss 1, Pp 1-

    The First Step Should be Done Before Used

    2017  Volume 2

    Keywords Translation ; Adaptation: Foreign Questionnaire ; Internal medicine ; RC31-1245
    Language English
    Publishing date 2017-04-01T00:00:00Z
    Publisher Interna Publishing
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article: COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive?

    Setiati, Siti / Marsigit, Jessica

    Acta medica Indonesiana

    2021  Volume 53, Issue 1, Page(s) 1–4

    Abstract: It has been a year since the Indonesian government announced its first COVID-19 identified in Jakarta. Since then, there have been more than 900,000 cases in Indonesia with case fatality rate (CFR) of 2.9%. The number of new cases per day is now ranging ... ...

    Abstract It has been a year since the Indonesian government announced its first COVID-19 identified in Jakarta. Since then, there have been more than 900,000 cases in Indonesia with case fatality rate (CFR) of 2.9%. The number of new cases per day is now ranging from 9,000 cases to almost 13,000 cases. Not only in Indonesia, but the number of new cases along with the mortality rate in other countries, such as Malaysia, Japan, United States, and Europe region also increased dramatically. COVID-19 vaccines are being investigated and the world hopes that vaccines will be the answer to tackle this pandemic. Is it really so? Immunization is an effort to induce immunity in individuals to prevent a disease or the complication related to the diseases that may be catastrophic. Immunization can be divided into passive, which is by giving certain type of antibody and active, which means that either we get the disease, or we get the antigen injected into our body.Having prior vaccination or past COVID-19 does not mean that someone is totally immune to COVID-19 as a recent study suggested that the antibody related to COVID-19 past infection is significantly decreasing after 3 months post-infection. Compliance to implementation of health protocol remained the most crucial strategy during this pandemic.
    MeSH term(s) Aged ; COVID-19/epidemiology ; COVID-19/prevention & control ; COVID-19 Vaccines/administration & dosage ; COVID-19 Vaccines/adverse effects ; Female ; Frail Elderly/statistics & numerical data ; Frailty/diagnosis ; Frailty/epidemiology ; Geriatric Assessment ; Humans ; Indonesia/epidemiology ; Male ; Risk Adjustment/methods ; Risk Adjustment/organization & administration ; Risk Factors ; SARS-CoV-2 ; Seroconversion ; Vaccination/methods ; Vaccination/standards ; Vaccination/statistics & numerical data
    Chemical Substances COVID-19 Vaccines
    Language English
    Publishing date 2021-04-05
    Publishing country Indonesia
    Document type Journal Article
    ZDB-ID 2474707-5
    ISSN 2338-2732 ; 0125-9326
    ISSN (online) 2338-2732
    ISSN 0125-9326
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Modifiable Risk Factors for Dementia in Indonesia's Urban Population.

    Azwar, Muhammad Khifzhon / Setiati, Siti

    Acta medica Indonesiana

    2021  Volume 53, Issue 1, Page(s) 31–41

    Abstract: Background: Indonesia is one of ten countries in the world with estimated number of dementia case exceeding a million. The number of elderly population living in Indonesian cities has exceeded the number in rural areas, but the country lacks data ... ...

    Abstract Background: Indonesia is one of ten countries in the world with estimated number of dementia case exceeding a million. The number of elderly population living in Indonesian cities has exceeded the number in rural areas, but the country lacks data representing the urban population better related to modifiable risk factors for dementia, prevention of which is crucial. We aimed to identify the modifiable risk factors for dementia in Indonesia's urban population.
    Methods: this case-control study used five-year data in Indonesia's national general hospital by tracing back medical record books of individuals aged 60 years and above in geriatric medicine outpatient clinic to the first hospital visit. Statistical analyses included bivariate and multivariate analyses to adjust for confounding factors appropriately.
    Results: data from 345 patients suggested that the significant risk factors for dementia were history of smoking (adjusted OR 2.860, 95% CI 1.559-5.246), history of hearing loss (adjusted OR 7.962, 95% CI 3.534-17.941), history of depression (adjusted OR 12.473, 95% CI 2.533-61.417), hypertension (adjusted OR 1.751, 95% CI 1.006-3.048), and diabetes mellitus (adjusted OR 2.561, 95% CI 1.482-4.425). Dementia patients had longer median duration of diabetes mellitus (12 years) than elderly without dementia (9 years) before the diagnosis of dementia. Single point late-life underweight condition and low educational attainment were not associated with dementia in Indonesia's urban setting. The risk factors for vascular dementia were largely similar to those of dementia.
    Conclusion: in Indonesian urban population, history of smoking, hearing loss, depression, hypertension, and diabetes mellitus are associated with dementia.
    MeSH term(s) Aged ; Aged, 80 and over ; Case-Control Studies ; Dementia/etiology ; Depression/complications ; Diabetes Mellitus ; Female ; Hearing Loss/complications ; Humans ; Hypertension/complications ; Indonesia ; Logistic Models ; Male ; Middle Aged ; Multivariate Analysis ; Risk Factors ; Smoking/adverse effects ; Urban Population
    Language English
    Publishing date 2021-04-04
    Publishing country Indonesia
    Document type Journal Article
    ZDB-ID 2474707-5
    ISSN 2338-2732 ; 0125-9326
    ISSN (online) 2338-2732
    ISSN 0125-9326
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Retraction

    I Gusti Putu Suka Aryana / Sandra Surya Rini / Siti Setiati

    Annals of Geriatric Medicine and Research, Vol 27, Iss 4, Pp 361-

    Denosumab’s Therapeutic Effect for Future Osteosarcopenia Therapy: A Systematic Review and Meta-Analysis

    2023  Volume 361

    Keywords Medicine ; R ; Geriatrics ; RC952-954.6
    Language English
    Publishing date 2023-12-01T00:00:00Z
    Publisher Korea Geriatrics Society
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top